Related Experiment Video

Updated: Mar 5, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

680

Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the

Carly M Goldstein1, Emily C Gathright2, Sarah Garcia3

  • 1Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University; Weight Control and Diabetes Research Center, The Miriam Hospital, Providence, RI.

Patient Preference and Adherence
|March 30, 2017
PubMed

Insights

Depression in cardiovascular disease (CVD) patients often leads to poor adherence to medications. An integrated care team approach can effectively manage depressive symptoms and improve medication adherence for better health outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Health Services Research

Background:

  • Depression is common in cardiovascular disease (CVD) patients and linked to adverse health outcomes.
  • Medication nonadherence is a significant factor contributing to poor outcomes in depressed CVD patients.
  • Various factors influence medication adherence, impacting the depression-adherence relationship in CVD.

Purpose of the Study:

  • To review literature on depression and medication adherence in CVD patients.
  • To examine challenges in measuring medication adherence.
  • To highlight the role of integrated care teams in improving outcomes for depressed CVD patients.

Main Methods:

  • Comprehensive literature review on depression and medication adherence in CVD.
  • Analysis of methods and challenges in measuring medication adherence.
  • Exploration of integrated care team strategies for managing depressive symptoms and medication-taking behavior.

Main Results:

  • Integrated care teams are well-positioned to enhance outcomes for depressed CVD patients.
  • Collaborative strategies can target both depressive symptoms and medication adherence.
  • Existing literature highlights the complex interplay between depression, adherence, and CVD outcomes.

Conclusions:

  • Integrated care models offer a promising approach to managing depressed CVD patients.
  • Further research is needed to refine integrated care strategies and address limitations.
  • Improved management of depression and medication adherence can significantly benefit CVD patients and their families.

Keywords:
cardiovascular diseasecollaborative carecomplianceelectronic monitoringintegrated caremedication adherenceself-management

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.6K

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
806
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
346
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.8K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
942